Education
About Us
Working with TipRanks
Follow Us
Pa Shun International Holdings Limited (HK:0574)
:0574
0574 Stock Chart & Stats
HK$0.05
<HK$0.01(2.04%)
At close: 4:00 PM EST
HK$0.05
<HK$0.01(2.04%)
Day’s Range― - ―
52-Week RangeHK$0.03 - HK$0.10
Previous CloseN/A
Volume290.00K
Average Volume (3M)1.15M
Market Cap
HK$88.50M
Enterprise ValueHK$104.57M
Total Cash (Recent Filing)HK$3.56M
Total Debt (Recent Filing)HK$40.42M
Price to Earnings (P/E)―
Beta0.24
Next Earnings
Mar 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,474,992,900
10 Day Avg. Volume798,200
30 Day Avg. Volume1,152,533
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.48
Price to Sales (P/S)0.75
P/FCF Ratio-36.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Industry ExposureOperating in Medical - Pharmaceuticals provides structurally steady end-market demand and regulatory entry barriers that can sustain long-term revenue opportunity versus cyclical sectors, supporting durable product demand and potential margin resilience over multiple years.
Public Listing (HKEX)Being listed on HKEX gives the company access to established capital markets and regulatory disclosure frameworks, supporting longer-term financing and investor access. This structural market access helps preserve options for equity or debt funding when needed.
Lean HeadcountA small workforce (97 employees) implies lower structural fixed payroll costs and potential operational agility. Over time this can improve scalability and cost control versus larger peers, aiding margin recovery if revenues stabilize or grow.
Bears Say
Declining Revenue TrendMaterial multi-year revenue decline erodes scale, reduces pricing leverage and increases unit costs, making margin recovery harder. Sustained top-line contraction weakens competitive position and limits reinvestment capacity for R&D or commercial expansion.
Negative Shareholders' EquityNegative shareholders' equity signals accumulated losses and elevated solvency risk, constraining borrowing capacity and restricting strategic flexibility. Over months this limits ability to raise debt or equity on favorable terms and increases restructuring risk.
Consistent Negative Free Cash FlowPersistent negative free cash flow indicates operations consume cash rather than generate it, forcing reliance on external funding. This undermines sustainable investment in products or commercialization and raises long-term liquidity and survival concerns.
Pa Shun International Holdings Limited News
0574 FAQ
What was Pa Shun International Holdings Limited’s price range in the past 12 months?
Pa Shun International Holdings Limited lowest stock price was HK$0.03 and its highest was HK$0.10 in the past 12 months.
What is Pa Shun International Holdings Limited’s market cap?
Pa Shun International Holdings Limited’s market cap is HK$88.50M.
When is Pa Shun International Holdings Limited’s upcoming earnings report date?
Pa Shun International Holdings Limited’s upcoming earnings report date is Mar 26, 2026 which is in 30 days.
How were Pa Shun International Holdings Limited’s earnings last quarter?
Pa Shun International Holdings Limited released its earnings results on Aug 11, 2025. The company reported -HK$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.007.
Is Pa Shun International Holdings Limited overvalued?
According to Wall Street analysts Pa Shun International Holdings Limited’s price is currently Overvalued.
Does Pa Shun International Holdings Limited pay dividends?
Pa Shun International Holdings Limited pays a Monthly dividend of HK$0.03 which represents an annual dividend yield of N/A. See more information on Pa Shun International Holdings Limited dividends here
What is Pa Shun International Holdings Limited’s EPS estimate?
Pa Shun International Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pa Shun International Holdings Limited have?
Pa Shun International Holdings Limited has 1,474,992,900 shares outstanding.
What happened to Pa Shun International Holdings Limited’s price movement after its last earnings report?
Pa Shun International Holdings Limited reported an EPS of -HK$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Pa Shun International Holdings Limited?
Currently, no hedge funds are holding shares in HK:0574
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Pa Shun International Holdings Limited
Pa Shun International Holdings Limited, an investment holding company, engages in the pharmaceutical distribution activities in the People's Republic of China. It operates through three segments: Pharmaceutical Distribution, Self-Operated Retail Pharmacies, and Pharmaceutical Manufacturing. The Pharmaceutical Distribution segment sells pharmaceutical products to wholesalers, franchise retail pharmacy chain stores, and hospitals and other medical institutions in rural areas. The Self-Operated Retail Pharmacies segment engages in the sale of pharmaceutical and healthcare products, cosmetic products, and daily necessities in self-operated retail pharmacies. The Pharmaceutical Manufacturing segment sells pharmaceutical products manufactured by the company. The company was formerly known as Pa Shun Pharmaceutical International Holdings Limited and changed its name to Pa Shun International Holdings Limited in June 2017. The company was incorporated in 2011 and is based in San Po Kong, Hong Kong. Pa Shun International Holdings Limited is a subsidiary of Praise Treasure Limited.
Technical Analysis
Sanai Health Industry Group Company Limited
―
Qianhai Health Holdings Ltd.
―
Wanjia Group Holdings Ltd.
―
New Ray Medicine International Holding Ltd.
―
Medicskin Holdings Ltd.
―